← Open Payments lookup

VIC LINDEN: Open Payments

NPI 1073772141 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$999 in 57 payments from 11 companies in 2025. Trend: 2023 $1,038 · 2024 $806 · 2025 $999

Food & beverage: $999
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$243
Lundbeck LLC12$219
ABBVIE INC.5$105
Axsome Therapeutics, Inc.4$96
Supernus Pharmaceuticals, Inc.6$89
Alkermes, Inc.3$70
Takeda Pharmaceuticals U.S.A., Inc.3$57
Otsuka America Pharmaceutical, Inc.2$39
Janssen Pharmaceuticals, Inc1$29
Bausch Health US, LLC1$29

Products named: REXULTI, CAPLYTA, VRAYLAR, Auvelity, Qelbree, ARISTADA, TRINTELLIX, SPRAVATO.

Industry payments across LA — which companies pay providers there.